| Literature DB >> 35896727 |
S Tolonen1, M Juonala2,3, M Fogelholm4, K Pahkala5,6, M Laaksonen4, M Kähönen7,8, H Sievänen9, J Viikari2, O Raitakari5,6,10.
Abstract
Previous studies suggest that saturated fat (SFA) intake may negatively impact on bone. However, few human studies on the topic exist. Women and men aged 31-46 years from the Cardiovascular Risk in Young Finns study attended the peripheral quantitative computed tomography and ultrasound bone measurements in 2008 (n = 1884-1953, ~ 56% women). In addition, fracture diagnoses in 1980-2018 were searched for the national health care registers and 431 participants had at least one fracture. Food consumption was gathered with the 48-h dietary recall interviews and food frequency questionnaire in 1980-2007. In the present study, radial, tibial, and calcaneal bone traits, and fractures were examined relative to the long-term intake of SFA. No consistent associations were seen between bone outcomes and SFA intake that would have replicated in both women and men. The only evidence for differential distributions was seen in cortical density and cortical-to-total area ratio at the radial shaft, and speed of sound at the calcaneus, which were 0.1-0.4% higher in women in the lowest tertile of SFA intake compared with the highest tertile. In addition, among men, the odds ratio (OR) of fractures was greater in the second (OR 1.86, 95% confidence interval (CI) 1.03-3.33) and third tertile of SFA intake (OR 2.45, 95% CI 1.38-4.36) compared with the lowest tertile, independently of many risk factors of osteoporosis. In this observational study, we found no robust evidence of the associations of dietary long-term SFA intake with bone outcomes. Therefore, additional studies are needed to confirm the association of dietary SFA with bone health in humans.Entities:
Keywords: Bone fracture; Dietary saturated fat; Quantitative computed tomography (QCT); Quantitative ultrasound (QUS)
Mesh:
Substances:
Year: 2022 PMID: 35896727 PMCID: PMC9474366 DOI: 10.1007/s00223-022-01008-5
Source DB: PubMed Journal: Calcif Tissue Int ISSN: 0171-967X Impact factor: 4.000
Background characteristics of women as mean values (SD) or frequencies (%, n) in the thirds of dietary saturated fat
| Dietary long-term intake of saturated fat, g/day | P value* | |||
|---|---|---|---|---|
| ≤ 27.43 | 27.44–35.44 | ≥ 35.45 | ||
| Age, years | 37.8 (5) | 37.6 (5) | 37.6 (4.9) | 0.84 |
| Height, cm | 166 (6.1) | 165.9 (5.2) | 165.9 (6.5) | 0.97 |
| Weight, kg | 69.8 (13.8) | 70.6 (15.7) | 69.3 (13.9) | 0.52 |
| Body mass index, kg/m2 | 25.3 (4.8) | 25.6 (5.4) | 25.2 (4.8) | 0.55 |
| Energy intake, kJ/day | 9635 (2860) | 8823 (2732) | 8941 (2808) | < 0.001 |
| Carbohydrate, E% | 50.4 (5) | 46.8 (5.1) | 44.5 (5) | < 0.001 |
| Fiber, g/day | 29.7 (11.1) | 23.3 (9.2) | 21.2 (8.1) | < 0.001 |
| Protein, E% | 17.4 (2.4) | 17.7 (2.4) | 17.2 (2.3) | 0.007 |
| Fat, E% | 29.1 (3.8) | 32.4 (3.9) | 35.4 (3.9) | < 0.001 |
| Polyunsaturated fat, E%/g/day | 5.1/13 (4.7) | 5.3/12.4 (4.6) | 5.2/12.3 (4.4) | 0.10 |
| Monounsaturated fat, E%/g/day | 9.8/24.9 (8.6) | 10.9/25.5 (9.5) | 11.6/27.5 (9.4) | < 0.001 |
| Dietary calcium, mg/day | 1419 (532) | 1322 (547) | 1352 (561) | 0.04 |
| Dietary vitamin D, μg/day | 7.5 (3) | 6.7 (3) | 6.1 (2.7) | < 0.001 |
| Intake of milk, g/day | 369 (284) | 320 (276) | 303 (272) | 0.003 |
| Intake of sour-milk products, g/day | 198 (176) | 178 (187) | 162 (184) | 0.03 |
| Intake of cheese, g/day | 36 (25) | 41 (33) | 49 (32) | < 0.001 |
| Serum calcidiol, nmol/l | 64.4 (22.1) | 59.8 (20.1) | 59.1 (19.2) | < 0.001 |
| Serum glucose, mmol/l | 5.2 (1) | 5.1 (0.6) | 5.2 (0.8) | 0.45 |
| Serum insulin, mU/l | 8.9 (10.3) | 9 (7.9) | 8.4 (6.3) | 0.55 |
| Serum total cholesterol, mmol/l | 4.9 (0.9) | 4.9 (0.8) | 5.0 (0.9) | 0.38 |
| Serum HDL-cholesterol, mmol/l | 1.4 (0.3) | 1.4 (0.3) | 1.5 (0.3) | 0.78 |
| Serum LDL-cholesterol, mmol/l | 2.9 (0.7) | 3 (0.7) | 3 (0.8) | 0.21 |
| Alcohol consumption, drinks/day | 0.5 (0.7) | 0.6 (0.7) | 0.6 (0.8) | 0.13 |
| Current daily smokers, % | 9.9 (40 women) | 15.5 (59) | 20.4 (79) | < 0.001 |
| Oral corticosteroid medication ≥ 1 month, % | 7.9 (27 women) | 8.1 (26) | 4.9 (17) | 0.17 |
| Those in manual work, % | 25.8 (93 women) | 29.2 (98) | 31 (104) | 0.38 |
| Physical activity index | 9.2 (1.7) | 8.7 (1.7) | 8.6 (1.7) | < 0.001 |
| Radial bone loading index | 382 (357) | 334 (319) | 319 (357) | 0.05 |
| Tibial bone loading index | 635 (627) | 523 (499) | 521 (584) | 0.02 |
*Tested with analysis of variance, Brown–Forsythe-test, or Chi-Square test
Background characteristics of men as mean values (SD) or frequencies (%, n) in the thirds of dietary saturated fat
| Dietary long-term intake of saturated fat, g/day | P value* | |||
|---|---|---|---|---|
| ≤ 35.58 | 35.59–48.97 | ≥ 48.98 | ||
| Age, years | 37.4 (4.9) | 37 (5.1) | 37.8 (4.9) | 0.08 |
| Height, cm | 179.5 (6.8) | 180.3 (6.6) | 179.3 (6.4) | 0.16 |
| Weight, kg | 84.6 (14.4) | 87.3 (16.2) | 87.3 (15.6) | 0.04 |
| Body mass index, kg/m2 | 26.2 (3.9) | 26.8 (4.3) | 27.1 (4.4) | 0.03 |
| Energy intake, kJ/day | 11,369 (3101) | 10,801 (4260) | 11,776 (4419) | 0.01 |
| Carbohydrate, E% | 47 (5.7) | 44 (4.7) | 41.9 (5.1) | < 0.001 |
| Fiber, g/day | 27.2 (11) | 22.3 (10.4) | 22 (10.4) | < 0.001 |
| Protein, E% | 17.5 (2.7) | 17.9 (2.4) | 17.4 (2.4) | 0.06 |
| Fat, E% | 30.2 (4.2) | 33.5 (3.6) | 37 (4.2) | < 0.001 |
| Polyunsaturated fat, E%/g/day | 5.3/15.8 (5.3) | 5.4/15.5 (6.3) | 5.5/17.1 (7.4) | 0.007 |
| Monounsaturated fat, E%/g/day | 10.4/31.3 (10.3) | 11.6/33 (14.2) | 12.6/39.1 (16.3) | < 0.001 |
| Dietary calcium, mg/day | 1505 (558) | 1490 (669) | 1638 (734) | 0.01 |
| Dietary vitamin D, μg/day | 9.6 (3.8) | 8.6 (3.7) | 8.8 (4.1) | 0.007 |
| Intake of milk, g/day | 484 (368) | 439 (350) | 502 (404) | 0.12 |
| Intake of sour-milk products, g/day | 148 (149) | 140 (180) | 143 (172) | 0.84 |
| Intake of cheese, g/day | 36 (28) | 44 (33) | 52 (40) | < 0.001 |
| Serum calcidiol, nmol/l | 58.1 (16.3) | 57.4 (17.6) | 54.6 (16.4) | 0.02 |
| Serum glucose, mmol/l | 5.5 (1.3) | 5.5 (0.8) | 5.5 (0.5) | 0.97 |
| Serum insulin, mU/l | 8.5 (6.7) | 10.3 (13.0) | 11.9 (37.3) | 0.19 |
| Serum total cholesterol, mmol/l | 5.2 (1) | 5.2 (1) | 5.2 (0.9) | 0.98 |
| Serum HDL-cholesterol, mmol/l | 1.2 (0.3) | 1.2 (0.3) | 1.2 (0.3) | 0.77 |
| Serum LDL-cholesterol, mmol/l | 3.3 (0.8) | 3.3 (0.8) | 3.3 (0.8) | 0.76 |
| Alcohol consumption, drinks/day | 1.5 (2.3) | 1.5 (1.6) | 1.3 (1.6) | 0.26 |
| Current daily smokers, % | 15.3 (48 men) | 25.4 (76) | 27.0 (86) | < 0.001 |
| Oral corticosteroid medication ≥ 1 month, % | 1.2 (3 men) | 2.2 (5) | 4.7 (12) | 0.04 |
| Those in manual work, % | 33 (96 men) | 39.5 (113) | 56.9 (174) | < 0.001 |
| Physical activity index | 9.2 (1.8) | 8.8 (1.8) | 8.3 (2) | < 0.001 |
| Radial bone loading index | 559 (637) | 384 (381) | 333 (376) | < 0.001 |
| Tibial bone loading index | 797 (910) | 585 (566) | 561 (658) | < 0.001 |
*Tested with analysis of variance, Brown–Forsythe-test, or Chi-Square test
Mean values (SD) of peripheral quantitative computed tomography (pQCT) in the thirds of dietary saturated fat in women
| Dietary long-term intake of saturated fat, g/day | ANCOVA* | |||
|---|---|---|---|---|
| pQCT bone traitsa | ≤ 27.43 | 27.44–35.44 | ≥ 35.45 | P for trend |
| Total area, mm2 | 315.7 (45.8) | 308.8 (39.4) | 316 (46.1) | 0.57 |
| BMC, mg | 201.1 (27.9) | 194.1 (26.4) | 201.1 (31) | 0.27 |
| Trabecular density, mg/cm3 | 208.2 (29.8) | 206 (29.4) | 208.3 (28.1) | 0.14 |
| Total area, mm2 | 94.1 (13.5) | 92.4 (12.4) | 94.5 (14.6) | 0.56 |
| Cortical area, mm2 | 75.5 (8.2) | 74.1 (7.8) | 75.7 (8.7) | 0.29 |
| Cortical density, mg/cm3 | 1212 (18.5) | 1212 (19.7) | 1210 (21.3) | 0.01 |
| BMC, mg | 183 (19.9) | 179.7 (19) | 183.2 (20.8) | 0.13 |
| Cortical-to-total area ratio | 0.809 (0.06) | 0.808 (0.06) | 0.808 (0.06) | 0.02 |
| SSI, mm3 | 206.8 (38.1) | 203 (36.7) | 208.5 (42.3) | 0.95 |
| Total area, mm2 | 821.1 (112) | 807 (96.9) | 817.9 (109.9) | 0.79 |
| BMC, mg | 523.9 (69) | 518.8 (72.7) | 521.6 (70.5) | 0.10 |
| Trabecular density, mg/cm3 | 229.5 (30.3) | 230.5 (31.5) | 226.5 (28.7) | 0.26 |
| Total area, mm2 | 341.9 (43.8) | 340.2 (40.9) | 345.1 (44.1) | 0.77 |
| Cortical area, mm2 | 247.2 (30.5) | 245.7 (29.1) | 249.3 (31.9) | 0.23 |
| Cortical density, mg/cm3 | 1170 (19.9) | 1168 (19.6) | 1169 (18.7) | 0.15 |
| BMC, mg | 577.9 (68.2) | 574 (67.1) | 582.3 (72.5) | 0.15 |
| Cortical-to-total area ratio | 0.725 (0.05) | 0.724 (0.05) | 0.724 (0.05) | 0.15 |
| SSI, mm3 | 1304 (237.1) | 1292 (221.3) | 1326 (245.4) | 0.50 |
aBMC, bone mineral content; SSI, stress–strain index
*Analysis of covariance (ANCOVA) included age, height, weight, energy intake, serum calcidiol concentration, calcium intake, physical activity, physical load of work, and smoking as covariates
Mean values (SD) of peripheral quantitative computed tomography (pQCT) in the thirds of dietary saturated fat in men
| Dietary long-term intake of saturated fat, g/day | ANCOVA* | |||
|---|---|---|---|---|
| pQCT bone traitsa | ≤ 35.58 | 35.59–48.97 | ≥ 48.98 | P for trend |
| Total area, mm2 | 408.8 (61.7) | 415.3 (62.3) | 428.9 (64.3) | 0.84 |
| BMC, mg | 296.8 (42) | 300.8 (43.9) | 313.4 (43.1) | 0.58 |
| Trabecular density, mg/cm3 | 248.6 (30.6) | 247.1 (32.8) | 250.5 (30.1) | 0.22 |
| Total area, mm2 | 134.6 (18.1) | 138.2 (19.4) | 144 (18.2) | 0.63 |
| Cortical area, mm2 | 106.3 (12.4) | 107.8 (13) | 111.9 (12.6) | 0.62 |
| Cortical density, mg/cm3 | 1185 (22.9) | 1180 (21.5) | 1179 (22.2) | 0.21 |
| BMC, mg | 251.8 (29.1) | 254.4 (29.8) | 263.8 (29.3) | 0.47 |
| Cortical-to-total area ratio | 0.794 (0.05) | 0.784 (0.06) | 0.780 (0.05) | 0.97 |
| SSI, mm3 | 332.9 (62.4) | 342.9 (61.4) | 362.6 (63.8) | 0.47 |
| Total area, mm2 | 977.3 (128.4) | 994.9 (141.6) | 989.4 (136) | 0.90 |
| BMC, mg | 702.9 (103.1) | 702.6 (104.3) | 704.2 (101.1) | 0.52 |
| Trabecular density, mg/cm3 | 257.3 (34) | 254.9 (34.9) | 254.9 (32.5) | 0.31 |
| Total area, mm2 | 430.3 (51.5) | 438.2 (51.4) | 438.2 (49.3) | 0.96 |
| Cortical area, mm2 | 319.5 (42.8) | 318.9 (39.7) | 319.7 (40.2) | 0.71 |
| Cortical density, mg/cm3 | 1148 (21.6) | 1146 (22.9) | 1147 (22.1) | 0.58 |
| BMC, mg | 732.8 (95) | 730.1 (85.8) | 732.8 (88) | 0.63 |
| Cortical-to-total area ratio | 0.743 (0.05) | 0.729 (0.05) | 0.731 (0.05) | 0.54 |
| SSI, mm3 | 1806 (319) | 1841 (301.3) | 1836 (295.8) | 0.94 |
aBMC, bone mineral content; SSI, stress–strain index
*Analysis of covariance (ANCOVA) included age, height, weight, energy intake, serum calcidiol concentration, calcium intake, physical activity, physical load of work, and smoking as covariates
Mean values (SD) of quantitative ultrasound bone measurements at calcaneus in the thirds of dietary saturated fat
| Dietary long-term intake of saturated fat, g/day | ANCOVA* | |||
|---|---|---|---|---|
| Women | ≤ 27.43 | 27.44–35.44 | ≥ 35.45 | P for trend |
| BUAa, dB/MHz | 81.4 (15.2) | 77.2 (16.8) | 77.7 (13) | 0.58 |
| SOSa, m/s | 1563 (28) | 1555 (31.5) | 1557 (25.7) | 0.04 |
| Men | ≤ 35.58 ( | 35.59–48.97 ( | ≥ 48.98 ( | |
| BUAa, dB/MHz | 82 (15.9) | 82.2 (16.1) | 80.7 (15.8) | 0.62 |
| SOSa, m/s | 1561 (27.4) | 1558 (27.5) | 1557 (29.1) | 0.38 |
aBUA, broadband ultrasound attenuation; SOS, speed of sound
*Analysis of covariance (ANCOVA) included age, height, weight, energy intake, serum calcidiol concentration, calcium intake, physical activity, physical load of work, and smoking as covariates
Fracture frequencies (%, n) in the thirds of dietary saturated fat
| Mean dietary long-term intake of saturated fat, g/day (SD) | P value* | |||
|---|---|---|---|---|
| 22 (4.2) | 31.3 (2.3) | 44.2 (11.2) | ||
| Women with previous fracture(s), % | 8.1 (40 women) | 6.7 (33) | 8.3 (41) | 0.62 |
| Of whom with lumbar spine or pelvis fracture, % | 0.6 (3) | 0.2 (1) | 0 (0) | 0.33 |
| Of whom with skull or facial bone fracture, % | 0.4 (2) | 0 (0) | 0.2 (1) | 0.78 |
| Of whom with cervical spine fracture, % | 0.2 (1) | 0 (0) | 0 (0) | 1.0 |
| Of whom with thoracic fracture, % | 0.8 (4) | 0.6 (3) | 0.8 (4) | 1.0 |
| Of whom with shoulder or upper arm fracture, % | 0.8 (4) | 1.2 (6) | 1.6 (8) | 0.56 |
| Of whom with forearm fracture, % | 2 (10) | 0.8 (4) | 2.4 (12) | 0.13 |
| Of whom with wrist or hand fracture, % | 0.4 (2) | 1.2 (6) | 0.6 (3) | 0.41 |
| Of whom with femoral fracture, % | 0.4 (2) | 0 (0) | 0.4 (2) | 0.56 |
| Of whom with lower leg fracture, % | 3 (15) | 2.2 (11) | 3 (15) | 0.69 |
| Of whom with foot fracture, % | 0.4 (2) | 0.6 (3) | 0 (0) | 0.38 |
*Tested with Chi-Square test